An Appraisal of Drug Development Timelines in the Era of Precision Oncology

Oncotarget - United States
doi 10.18632/oncotarget.10588
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Individualized Prognostic Calculators in the Precision Oncology Era

Oncotarget
Oncology
2019English

Ethical Considerations for the Clinical Oncologist in an Era of Oncology Drug Shortages

Oncologist
Cancer ResearchMedicineOncology
2014English

Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies

Oncologist
Cancer ResearchMedicineOncology
2017English

Pcn299 - A Review of Appraisal Timelines in Oncology: Does Reimbursement Through the Cancer Drugs Fund (Cdf) Delay Patient Access?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Development of Biosimilars in an Era of Oncologic Drug Shortages

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Regarding “Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies”

Oncologist
Cancer ResearchMedicineOncology
2017English

Biomarkers in Oncology Drug Development

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2008English

Streamlining Detection of Fusion Genes in Colorectal Cancer: Having “Faith” in Precision Oncology in the (Tissue) “Agnostic” Era

Cancer Research
Cancer ResearchOncology
2019English

Personal Mutanomes Meet Modern Oncology Drug Discovery and Precision Health

Pharmacological Reviews
Molecular MedicinePharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy